AVA Conference Adelaide 2016

Veterinarians are confronted with a multitude of products that are rapidly being developed for the treatment and often prevention of degenerative joint disease in horses. To say this is a challenging situation, especially for the new graduates, is an understatement. While there are some treatments that have been around for a long time with well established efficacy, more recently a variety of products are on the market to challenge these. While some are still used via the intra-articular route, many are available as oral products or intra-muscular or intra-venous drugs. The decision as to what to use, how effective each drug is and also what evidence is available to support the claims of each product will be discussed.
While the proprietary products have established information many of the more recent drugs do not and in fact many are not registered for use in horses so choosing a safe and effective product is becoming a bigger challenge for the veterinarian